Thryvv : ratio page

Titan Bio-Tech

Overview Articles Financials Ratios Shareholding Peers

Financial Ratios

View
Order
Financial Ratios
Mar2025
Mar2024
Mar2023
Mar2022
Mar2021
Valuation Parameters:
PE(x)
16.18
17.56
6.55
9.99
5.05
PCE(x)
15.52
16.17
6.89
9.00
4.52
Price/Book(x)
2.27
3.27
1.48
2.51
2.23
Yield(%)
0.47
0.38
0.91
0.57
0.81
EV/Net Sales(x)
2.20
2.68
1.14
1.76
1.14
EV/Core EBITDA(x)
11.76
12.22
5.24
6.75
3.45
EV/EBIT(x)
13.70
13.47
5.71
7.28
3.65
EV/CE(x)
2.22
3.13
1.41
2.32
1.46
MCap / Sales
2.23
2.66
1.13
1.75
1.08
Growth Ratio:
Net Sales Growth(%)
-4.65
13.94
16.55
-13.14
79.05
Core EBITDA Growth(%)
-18.57
14.52
-2.32
-31.43
237.04
EBIT Growth(%)
-23.03
13.29
-3.28
-32.84
248.46
PAT Growth(%)
-22.79
12.55
-3.04
-31.61
304.54
EPS Growth(%)
-13.36
0.04
14.57
-28.52
329.32
Financial Stability Ratios:
Total Debt/Equity(x)
0.01
0.05
0.06
0.09
0.21
Current Ratio(x)
3.59
2.94
2.74
2.95
2.33
Quick Ratio(x)
1.45
1.27
1.43
1.51
1.24
Interest Cover(x)
31.39
27.95
38.69
34.22
25.72
Total Debt/Mcap(x)
0.01
0.02
0.04
0.03
0.09
Operational & Financial Ratios:
Earnings Per Share (Rs)
26.06
30.07
30.06
26.24
36.71
CEPS(Rs)
27.16
32.67
28.59
29.11
41.05
DPS(Rs)
2.00
2.00
1.80
1.50
1.50
Book NAV/Share(Rs)
185.64
161.49
133.00
104.36
83.21
Tax Rate(%)
25.02
24.95
25.22
25.15
25.76
Margin Ratios:
Core EBITDA Margin(%)
16.25
20.89
20.50
25.31
32.47
EBIT Margin(%)
16.09
19.93
20.04
24.15
31.24
Pre Tax Margin(%)
15.58
19.22
19.53
23.45
30.02
PAT Margin (%)
11.68
14.42
14.60
17.55
22.29
Cash Profit Margin (%)
14.34
16.45
16.41
19.47
23.85
Performance Ratios:
ROA(%)
10.58
15.44
16.37
19.16
33.50
ROE(%)
12.74
19.45
21.44
27.98
58.74
ROCE(%)
17.00
25.39
27.40
33.74
60.80
Asset Turnover(x)
0.91
1.07
1.12
1.09
1.50
Sales/Fixed Asset(x)
2.06
2.65
2.84
2.62
3.29
Working Capital/Sales(x)
2.55
3.09
3.00
2.64
3.60
Efficiency Ratios:
Fixed Capital/Sales(x)
0.49
0.38
0.35
0.38
0.30
Receivable days
43.71
44.12
47.36
50.91
38.45
Inventory Days
112.33
90.92
89.79
99.29
77.64
Payable days
21.58
21.53
25.39
24.97
23.89